Free shipping on all orders over $ 500

Ofatumumab

Cat. No. M1527

All AbMole products are for research use only, cannot be used for human consumption.

Ofatumumab Structure
Synonym:

Arzerra

Size Price Availability Quantity
2mg USD 600 In stock
5mg USD 900 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ofatumumab is a humanised anti-CD20 monoclonal antibody whose epitope is distinct from that of rituximab. The CD20 antigen is expressed on solely B cell lymphocytes. Compared with rituximab, ofatumumab binds more tightly to CD20 with a slower off-rate. Ofatumumab causes cytotoxicity in the cells that express CD20 by means of complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC).

Chemical Information
Molecular Weight 146059.83
Formula C6480H10022N1742O2020S44
CAS Number 679818-59-8
Form Liquid
Storage -80°C for long term
References

[1] Lin TS, et al. Pharmgenomics Pers Med. Ofatumumab: a novel monoclonal anti-CD20 antibody.

[2] Zhang B, et al. MAbs. Ofatumumab.

Related CD20 Products
Obinutuzumab

Obinutuzumab (GA101) is a fully humanized monoclonal antibody that binds to an epitope on CD20.

Rituximab

Rituximab is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM, MW: 143.86 KD.

Tositumomab

Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes.

Glofitamab

Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell lymphoma.

Ripertamab

Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).

  Catalog
Abmole Inhibitor Catalog




Keywords: Ofatumumab, Arzerra supplier, CD20, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.